CN Stock MarketDetailed Quotes

600276 Jiangsu Hengrui Pharmaceuticals

Watchlist
  • 45.96
  • -1.95-4.07%
Market Closed Feb 28 15:00 CST
293.18BMarket Cap53.82P/E (TTM)

Jiangsu Hengrui Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jiangsu Hengrui Pharmaceuticals Q4 2024 Estimates Date

Currency：CNYMar 31, 2025

Estimate YoY
Revenue
7.09B
+22.19%
EPS
0.25
+88.46%
Analyst Rating
Strong Buy

Mar 1, 2025

Jiangsu Hengrui Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.131B--
Mar 31, 20252024/Q4-- / 7.095B--
Oct 25, 20242024/Q36.589B / 6.734B--
Aug 22, 20242024/Q27.603B / 6.648B--
Apr 18, 20242024/Q15.998B / 6.071B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.131B--
Mar 31, 20252024/Q4-- / 7.095B--
Oct 25, 20242024/Q36.589B / 6.734B--
Aug 22, 20242024/Q27.603B / 6.648B--
Apr 18, 20242024/Q15.998B / 6.071B--

Unlock Free Earnings Estimates

Jiangsu Hengrui Pharmaceuticals Earnings Reports

  • Hengrui Pharmaceutical Report for the Third Quarter of 2024

    Oct 24, 2024 12:00 ET

  • Jiangsu Hengrui Pharmaceuticals Semi-Annual Report for 2024

    Aug 21, 2024 12:00 ET

  • Jiangsu Hengrui Pharmaceuticals 2024 Interim Report Summary

    Aug 21, 2024 12:00 ET

  • Summary of Hengrui Pharmaceutical's 2023 Annual Report

    Apr 17, 2024 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    LINTEX
    920106
    91.00 +30.00%
    LINGOOD
    833284
    27.92 +29.98%
    NTGEC
    870436
    24.93 +29.98%
    CG MED EQUIP.
    838810
    19.82 +29.97%
    Jiayu Holding
    300117
    1.00 +20.48%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Mar 1, 2025

    Strong Buy

    • Strong Buy

      92.31%

    • Buy

      5.13%

    • Hold

      2.56%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Monoclonal Antibody Concept
    Monoclonal Antibody Concept
    Intraday-0.84%
    Securities and Fund Holdings
    Securities and Fund Holdings
    Intraday-1.10%
    Hakuba Stock
    Hakuba Stock
    Intraday-1.15%